Share
Experts at the University of Nottingham will investigate possible treatments for cholangiocarcinoma (bile duct cancer) as part of a new collaboration with the AMMF, the UK’s only cholangiocarcinoma charity.
Cholangiocarcinoma, is a particularly deadly disease with limited treatment options, and so new treatments are urgently needed. As part of a new collaboration, AMMF will support PhD student Grace Martin from the University’s School of Medicine, along with her supervisor Dr Sheela Jayaraman, to investigate new treatments for the disease.
The project is based on the finding that specific proteins known as transcription factors are higher in cholangiocarcinoma and are responsible for driving tumour growth and tumour invasion. As part of the new research, Grace will explore new ways to decrease the amount of these proteins in the tumour.